Home » Authors » James Etheridge

Articles by James Etheridge

Cerenis Brings In $30.5M For HDL-Enhancing Drugs

Aug. 24, 2005

By James Etheridge

Oncodesign Developing Novel Cancer Treatments

Aug. 24, 2005

By James Etheridge

Cerenis Brings In $30.5M For HDL-Enhancing Drugs

Aug. 24, 2005

By James Etheridge

Cerenis Brings In $30.5M For HDL-Enhancing Drugs

Aug. 24, 2005

By James Etheridge

Cerenis Brings In $30.5M For HDL-Enhancing Drugs

Aug. 24, 2005

By James Etheridge

Oncodesign Developing Novel Cancer Treatments

Aug. 24, 2005

By James Etheridge

Biosystems International Aiming For Drug, Diagnostic Biomarkers

Aug. 17, 2005

By James Etheridge

Stallergènes Has Common Allergy Treatment Focus

Aug. 10, 2005

By James Etheridge

Stallergènes Has Common Allergy Treatment Focus

Aug. 10, 2005

By James Etheridge

Nucleis Planning Branches In Montreal, Atlanta, Singapore

Aug. 3, 2005

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...